GlassScriptPhysician profile
Robert L Feldman
NPI 1346345550
$14,226.13
in general payments reported to CMS, 2019-2025
22 companies · $396 in 2025
The $396 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,356 · 2020: $5,620 · 2021: $118 · 2022: $213 · 2023: $299 · 2024: $1,223 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890 · Long Term Medical Supply Or Device Loan: $28.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,890.33 |
| Long Term Medical Supply Or Device Loan | $28.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,666.43 | 2019-2023 | Ranger |
| Medtronic, INC. | $724.68 | 2021-2025 | Ffrangio, Symplicity G3, Corevalve Evolut R |
| Abiomed | $406.91 | 2024-2025 | Impella |
| Teleflex LLC | $301.43 | 2024 | Manta |
| Edwards Lifesciences Corporation | $209.50 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Endologix LLC | $180.19 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.24 | 2019-2024 | Lifevest |
| Inari Medical, INC. | $115.70 | 2022 | |
| Janssen Pharmaceuticals, INC | $98.46 | 2019 | |
| Penumbra, INC. | $87.93 | 2023-2025 | Penumbra System, Indigo System, Ruby Coil |
| Abbott Laboratories | $68.66 | 2024-2025 | Diamondback Coronary, Optis |
| Medtronic Vascular, INC. | $63.54 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $34.84 | 2019 | |
| Baxter Healthcare | $28.41 | 2023 | Hillrom - Cp 150 Resting Electrocardiograph |
| Recor Medical INC | $24.99 | 2024 | Paradise Renal Denervation System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $22.48 | 2025 | Irrisept |
| Cardiva Medical, INC. | $19.38 | 2019 | |
| Cook Medical LLC | $18.01 | 2020 | |
| Alydia Health | $13.35 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,846,416.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.